Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04657991
Title A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Pfizer
Indications

skin melanoma

Therapies

Pembrolizumab

Binimetinib + Encorafenib + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU

Additional content available in CKB BOOST